Accredited Investors Inc. Durect Corp Transaction History

Accredited Investors Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 16, 2021	BUY	$1.86 - $2.87 $33,480 - $51,660	18,000 Added 36.0%	68,000 $135,000
Q2 2020 Jul 29, 2020	BUY	$1.33 - $2.76 $26,600 - $55,199	20,000 Added 66.67%	50,000 $116,000
Q4 2018 Feb 13, 2019	BUY	$0.48 - $1.1 $14,400 - $33,000	30,000 New	30,000 $14,000
Q3 2018 Oct 23, 2018	SELL	$1.06 - $1.69 $31,800 - $50,700	-30,000 Closed	0 $0
Q3 2017 Oct 30, 2017	BUY	$1.55 - $1.82 $46,500 - $54,600	30,000	30,000 $53,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $180M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Accredited Investors Inc., based on Form 13F filings with the SEC.

Stay updated on Accredited Investors Inc. with notifications on news.